CD8A and cancer: One common mechanism that IL-17A–producing Vγ4+ and Vγ6+ cells share to foster cancer progression is the stimulation of granulopoiesis and recruitment of neutrophils to primary and secondary tumors that suppress anti-tumor CD8+ T cells.